BioWorld MedTech

Dec. 22, 2010

FDA approves Medtronic's Endurant AAA stent graft

Medtronic (Minneapolis) has received FDA approval to sell its Endurant AAA stent graft system in the U.S. for the minimally invasive treatment of AAA, a largely unknown and often fatal condition. (Medical Device Daily) Read More

Lap-Band changes game or gastric bypass market

Report from Europe: Spartan Bioscience garners CE IVD mark for DNA test

Washington roundup: Smith sets up new subcommittee for House Judiciary Committee

Financings roundup: Cambridge Heart raises $2.9M in private placementFinancings roundup: Cambridge Heart raises $2.9M in private placement

MDD's food for med-tech thought

HIT roundup: Medseek in partnership with BayCare for eHealth solutions

Agreements/contracts: OSI divison receives $3M order for patient monitoring tech

Product Briefs

Medtronic reports the death of former CEO Winston Wallin

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 29, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 29, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...